Clinically-aligned
neurotechnologies
created with
compassion
and purpose.
Sanmai is the first Public Benefit Corporation in the neurotechnology sector with a commitment to create affordable, accessible, and effective mental wellbeing solutions.
Low-intensity Transcranial Focused Ultrasound Device
Sanmai's world-leading ultrasound and engineering experts are building the first precise, non-invasive, personalized deep brain modulation wearable intended to transform mental health care.
TARGETING ANXIETY
Clinically significant reduction in anxiety in 71% of anxious participants (Sanmai pilot data).
Clinical effects in eight sessions in treatment-resistant anxious patients with another device (Mahdavi et al., 2023).
-
Targeting Anxiety
Clinically significant reduction in anxiety in 71% of anxious participants (Sanmai pilot data).
Clincal effects in eight sessions in treatment-resistant anxious patients (Mahdavi et al., 2023).
Available Soon
Sanmai's first clinical MVP will be available at the end of 2024. Clinics interested in our medical device can contact us for more information.
Safe. Effective. Accessible.
Sanmai was created as a public benefit corporation by world-leading experts in neuromodulation and ultrasound, clinical science and engineering.
FEATURED NEWS
Keep up to date with Sanmai's progress and field-leading research.
Clinical Study • Posted 2023-12-13
The Effects of Noninvasive Neuromodulation on Mental Wellness, Behavior, and Electrophysiology
The purpose of the study is to test the effects of brief, low-intensity transcranial focused ultrasound (TUS) on electrophysiological, behavioral, and cognitive markers related to anxiety disorders.
